Revised SPC: Trelegy Ellipta 92 micrograms/55 micrograms/22 micrograms (fluticasone furoate/umeclidinium bromide/vilanterol trifenatate) inhalation powder, pre-dispensed
SPC updated with adverse reactions of hypersensitivity reactions, including anaphylaxis, angioedema, urticaria, and rash.
Source:
electronic Medicines compendium